Diagnostic and Biotech

2015-2019 Global Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies -Molecular Diagnostics, Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

  • VPG327257
  • 821 Pages
  • September 2015
  • Diagnostic and Biotech

Complete report $35,500. DataPack (test volumes, sales forecasts, supplier shares) $22,400.


2015-2019 Global Automated Microbiology Market is a new seven-countrystrategic analysis of the major business opportunities emerging in the automated microbiology market during the nextfive years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.



Rationale


The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.


The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.


The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.


This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.


Worldwide Market Overview


- Estimated universe of laboratories performing microbiology testing by country.

- Specimen, test volume and sales forecasts by country.


Geographic Coverage


France, Germany, Italy, Japan, Spain, UK, USA


Market Segmentation Analysis


- Sales and market shares for major suppliers by individual test and country.


- Volume and sales forecasts for over 100 infectious disease

assays by individual test and country:


- Test volume estimates by method (molecular, serology/immunodiagnostics,

culture/microscopy).


- Review of the market dynamics, trends, structure, size, growth

and major suppliers by country.


Specimen Types


- Urine

- Sterile Fluids: Blood, Serum, CSF

- Throat Swabs, Respiratory Secretions

- Genital Secretions

- Stool

- Abscess/Wound

- Sputum

- Saliva


Applications


-Microbial Identification

-Antibiotic Susceptibility

-Urine Screening

-Blood Cultures


Review of Major Automated Systems


- Review of major automated molecular diagnostic, multipurpose, specialized,

microbial identification, antibiotic susceptibility, blood culture, urine screening,

and immunodiagnostic analyzers.


- The report profiles analyzers manufactured by Abbott, Alifax, Anagen,

BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad,

Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J,

Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens,

Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.


Infectious Diseases Analyzed in the Report


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease,

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,

Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,

Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.


Technology Review


- Assessment of molecular diagnostic, monoclonal antibody,

immunoassay,and other technologies and their potential

applications for the microbiology market.


- Global listings of companies developing or marketing microbiology

products by individual test.


Competitive Assessments


- Strategic assessments of major suppliers and emerging market entrants,

including their sales, product portfolios, marketing tactics, collaborative

arrangements and new products in R&D.


- The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies,

Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux,

Bio-Rad, Biotest, Cepheid, CellMark Forensics/LabCorp, Decode Genetics, Diadexus, Diamedix, DiaSorin, Eiken Chemical,

Elitech Group,
Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, Illumina,

ID Biomedical/GSK, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics,
Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Sierra Molecular, Shimadzu, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.


Opportunities and Strategic Recommendations


- Emerging opportunities for new analyzers, reagents kits,

IT and other products with significant market appeal during the next five years.


- Design criteria for decentralized testing products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Contains 821 pages and 371 tables


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Plasma Fractionation Market - Opportunities and Forecasts, 2015 - 2020

Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Veterinary Diagnostics Market (Products, Animals, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

Global Next Generation Sequencers Market (Applications, Technology, Requirements for processing, End-Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Next generation sequencers are used in sequencing technologies which can process millions of reactions in a massive parallel fashion, unlike older methods which were limited to a single or few ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Life Science and Chemical Instrumentation Market - Opportunities and Forecasts, 2015 - 2020

Life science and chemical instrumentation is used in research & development activities in industrial laboratories, biotechnology industry, pharmaceutical industries, and academic institutes. It is also used in testing the quality ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Enteric Disease Testing Market (Therapeutics, Technologies and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>